Journal of Clinical Medicine (Apr 2024)

Clinical Trajectory and Risk Stratification for Heart Failure with Preserved Ejection Fraction in a Real-World Cohort of Patients with Suspected Coronary Artery Disease

  • Guglielmo Gioia,
  • Karl-Patrik Kresoja,
  • Sebastian Rosch,
  • Anne Schöber,
  • Elias Harnisch,
  • Maximilian von Roeder,
  • Markus Scholz,
  • Sylvia Henger,
  • Berend Isermann,
  • Holger Thiele,
  • Philipp Lurz,
  • Karl-Philipp Rommel

DOI
https://doi.org/10.3390/jcm13072092
Journal volume & issue
Vol. 13, no. 7
p. 2092

Abstract

Read online

Background: Heart failure with preserved ejection fraction (HFpEF) is a widespread condition with significant morbidity and mortality. Its clinical heterogeneity may delay the diagnosis. Aim: To identify predictors of HFpEF-related hospitalizations in ambulatory patients presenting with elevated cardiovascular risk, suspected coronary artery diseases (CADs), and positive HFpEF screenings. Methods: Consecutive patients presenting with suspected CAD, enrolled in the observational LIFE-Heart study (2006–2014, NCT00497887), and meeting HFpEF criteria per the 2016 European Society of Cardiology (ESC) guidelines were categorized according to the presence of “overlapping conditions” potentially masking or contributing to their symptoms. Additional stratification using the H2FPEF score (Results: Of 1054 patients (66 ± 10 years, 60% male, NT-pro-BNP 286, IQR 183–574 pg/mL), 53% had overlapping conditions, while 47% had “isolated HFpEF”. The H2FPEF scores classified 23%, 57%, and 20% as low-, intermediate-, and high-risk, respectively, with consistent proportions across patients with and without overlapping conditions (p = 0.91). During the follow-up observational phase, 54% were rehospitalized, 22% experienced heart failure (HF) rehospitalizations, and 11% of patients died. Multivariable logistic regression revealed a high-risk H2FPEF category as an independent predictor of HF rehospitalization in the overall cohort (odds ratio: 3.4, CI: 2.4–4.9, p 2FPEF score ≥ 6 was independently associated with higher mortality rates (hazard ratio: 1.8, CI: 1.2–2.6, p Conclusions: Ambulatory patients presenting for suspected CAD and meeting HFpEF screening criteria face elevated risks for rehospitalizations over six years. Regardless of concomitant diagnoses, quantifying cardiac damage with the H2FPEF score helps in risk-stratifying patients for HF hospitalization and mortality.

Keywords